Stem cell treatment for severe covid-19
Part of Infections, Lungs & breathing clinical trials.
This trial studies whether a new treatment using stem cells from healthy donors can help people with severe or critical COVID-19. The goal is to see if it reduces inflammation and helps you recover faster.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have a positive COVID-19 test (PCR test).
- Your COVID-19 illness must be classified as severe or critical.
- You cannot be in another clinical trial at the same time.
- You must not have serious health problems that could affect your survival, like blood disorders, active bleeding, or severe malnutrition.
- You must not be currently on ECMO (a machine that adds oxygen to your blood) or CRRT (a type of dialysis).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-phase study tests immune cells from a matched family donor (made to target the COVID-19 virus) to see if they can help people with mild-to-moderate COVID-19 who are hospitalized and at higher risk for getting sicker. It aims to check safety first and also look for signs of benefit.
This study tests a treatment made from placental cells that may help reduce COVID-19 symptoms. It is for adults with mild to moderate symptoms who are overweight or obese.
This trial tests if adding stem cells or their growth liquid to standard sepsis treatment helps adults with severe breathing problems. It may improve recovery for those whose family agrees to the study.
This trial tests whether an injection of stem cells from umbilical cords can help people with severe ARDS (a type of lung failure) recover faster. It is for those who have not improved after standard treatment and whose ARDS is caused by an infection (not COVID-19).
This trial tests a treatment made from human umbilical cord cells to help the body fight severe infections (sepsis). It might reduce inflammation and improve recovery.
This trial tests whether immune-supporting treatment made from exosomes can help people with critically severe COVID-19 and lung damage. If you qualify, you may receive this therapy as part of the study to see if it improves outcomes.
Hear when a new Corona Virus Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.